Pharmaceutical implants: classification, limitations and therapeutic applications

References

• Afrooz H, Ahmadi F, Fallahzadeh F, Mousavi-Fard SH, Alipour S. 2017. Design and characterization of paclitaxel-verapamil co-encapsulated PLGA nanoparticles: potential system for overcoming P-glycoprotein mediated MDR. J Drug Deliv Sci Tech. 41:174–181.
   Web of Science ®Google Scholar
• Agarwal P, Rupenthal I. 2013. Injectable implants for the sustained release of protein and peptide drugs. Drug Discov Today. 18(7-8):337–349.
   PubMed Web of Science ®Google Scholar
• Aguilar LE, Thomas RG, Moon MJ, Jeong YY, Park CH, Kim CS. 2018. Implantable chemothermal brachytherapy seeds: a synergistic approach to brachytherapy using polymeric dual drug delivery and hyperthermia for malignant solid tumor ablation. Eur J Pharm Biopharm. 129:191–203.
   PubMed Web of Science ®Google Scholar
• Al-Jawadi S, Capasso P, Sharma M. 2018. The road to market implantable drug delivery systems: a review on US FDA’s regulatory framework and quality control requirements. Pharm Dev Technol. 23(10):953–963.
   PubMed Web of Science ®Google Scholar
• Allababidi S, Shah JC. 1998. Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation. J Pharm Sci. 87(6):738–744.
   PubMed Web of Science ®Google Scholar
• Amann LC, Gandal MJ, Lin R, Liang Y, Siegel SJ. 2010. In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharm Res. 27(8):1730–1737.
   PubMed Web of Science ®Google Scholar
• Amsden B. 2015. Novel biodegradable polymers for local growth factor delivery. Eur J Pharm Biopharm. 97(Pt B):318–328.
   PubMed Web of Science ®Google Scholar
• Andani MT, Shayesteh Moghaddam N, Haberland C, Dean D, Miller MJ, Elahinia M. 2014. Metals for bone implants. Part 1. Powder metallurgy and implant rendering. Acta Biomater. 10(10):4058–4070.
   PubMed Web of Science ®Google Scholar
• Appel B, Maschke A, Weiser B, Sarhan H, Englert C, Angele P, Blunk T, Göpferich A. 2006. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. Int J Pharm. 314(2):170–178.
   PubMed Web of Science ®Google Scholar
• Aqil F, Jeyabalan J, Kausar H, Bansal SS, Sharma RJ, Singh IP, Vadhanam MV, Gupta RC. 2012. Multi-layer polymeric implants for sustained release of chemopreventives. Cancer Lett. 326(1):33–40.
   PubMed Web of Science ®Google Scholar
• Arsiwala A, Desai P, Patravale V. 2014. Recent advances in micro/nanoscale biomedical implants. J Control Release. 189:25–45.
   PubMed Web of Science ®Google Scholar
• Bagherifard S. 2017. Mediating bone regeneration by means of drug eluting implants: from passive to smart strategies. Mater Sci Eng C Mater Biol Appl. 71:1241–1252.
   PubMed Web of Science ®Google Scholar
• Balogun OR, Adeniran AS, Adewole AA. 2016. Haematological and biochemical effects of etonogestrel subdermal implant (Implanon) in Ilorin Nigeria. Int J Health Sci (Qassim). 10(4):499–506.
   PubMedGoogle Scholar
• Barnwal P, Das S, Mondal S, Ramasamy A, Maiti T, Saha A. 2017. Probuphine® (buprenorphine implant): a promising candidate in opioid dependence. Ther Adv Psychopharmacol. 7(3):119–134.
   PubMed Web of Science ®Google Scholar
• Bastiancich C, Danhier P, Préat V, Danhier F. 2016. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. J Control Release. 243:29–42.
   PubMed Web of Science ®Google Scholar
• Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. 2006. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 119(12):1056–1061.
   PubMed Web of Science ®Google Scholar
• Benagiano G, D’Arcangues C, Harris Requejo J, Schafer A, Say L, Merialdi M. 2012. The special programme of research in human reproduction: forty years of activities to achieve reproductive health for all. Gynecol Obstet Invest. 74(3):190–217.
   PubMed Web of Science ®Google Scholar
• Bennewitz MF, Saltzman WM. 2009. Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics. 6(2):323–336.
   PubMed Web of Science ®Google Scholar
• Bhatia P, Nangia S, Aggarwal S, Tewari C. 2011. Implanon: subdermal single rod contraceptive implant. J Obstet Gynecol India. 61(4):422–425.
   PubMedGoogle Scholar
• Bhattarai G, Lee Y-H, Lee M-H, Park I-S, Yi H-K. 2015. Insulin-like growth factor binding protein-3 affects osteogenic efficacy on dental implants in rat mandible. Mater Sci Eng C Mater Biol Appl. 55:490–496.
   PubMed Web of Science ®Google Scholar
• Bhusal P, Harrison J, Sharma M, Jones DS, Hill AG, Svirskis D. 2016. Controlled release drug delivery systems to improve post-operative pharmacotherapy. Drug Deliv Transl Res. 6(5):441–451.
   PubMed Web of Science ®Google Scholar
• Blumenthal PD, Voedisch A, Gemzell-Danielsson K. 2011. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Hum Reprod Update. 17(1):121–137.
   PubMed Web of Science ®Google Scholar
• Borges AMR. 2016. Development of subcutaneous prolonged release of protein drugs by implants. Coimbra, Portugal: Universidade de Coimbra.
   Google Scholar
• Bose S, Tarafder S. 2012. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 8(4):1401–1421.
   PubMed Web of Science ®Google Scholar
• Bota DA, Desjardins A, Quinn JA, Affronti ML, Friedman HS. 2007. Interstitial chemotherapy with biodegradable BCNU (Gliadel®) wafers in the treatment of malignant gliomas. Ther Clin Risk Manag. 3(5):707–715.
   PubMedGoogle Scholar
• Brudno Y, Mooney D. 2015. On-demand drug delivery from local depots. J Control Release. 219:8–17.
   PubMed Web of Science ®Google Scholar
• Campos LW, Pope JE. 2018. Intrathecal drug delivery: trialing. In: Diwan S, Deer T, editor. Advanced procedures for pain management. Switzerland: Springer Nature. p. 385–392.
   Google Scholar
• Carvajal G, Dupoiron D, Seegers V, Lebrec N, Boré F, Dubois P-Y, Leblanc D, Delorme T, Jubier-Hamon S. 2018. Intrathecal drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a comprehensive cancer center. Anesth Analg. 126(6):2038–2046.
   PubMed Web of Science ®Google Scholar
• Chen X, Wu Q-S, Meng F-C, Tang Z-H, Chen X, Lin L-G, Chen P, Qiang W-A, Wang Y-T, Zhang Q-W, et al. 2016. Chikusetsusaponin IVa methyl ester induces G1 cell cycle arrest, triggers apoptosis and inhibits migration and invasion in ovarian cancer cells. Phytomedicine. 23(13):1555–1565.
   PubMed Web of Science ®Google Scholar
• Chen Y, Traore YL, Li A, Fowke KR, Ho EA. 2014. Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine. Drug Des Devel Ther. 8:1801–1815.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Z, Smith C, Sankar J. 2014. Recent advances on the development of magnesium alloys for biodegradable implants. Acta Biomater. 10(11):4561–4573.
   PubMed Web of Science ®Google Scholar
• Chennamaneni SR, Mamalis C, Archer B, Oakey Z, Ambati BK. 2013. Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. J Control Release. 167(1):53–59.
   PubMed Web of Science ®Google Scholar
• Clark JT, Clark MR, Shelke NB, Johnson TJ, Smith EM, Andreasen AK, Nebeker JS, Fabian J, Friend DR, Kiser PF, et al. 2014. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. PLoS One. 9(3):e88509.
   PubMed Web of Science ®Google Scholar
• Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B, et al. 1993. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 78(2):226–232.
   PubMed Web of Science ®Google Scholar
• Croxatt HB. 2002. Progestin implants for female contraception. Contraception. 65(1):15–19.
   PubMed Web of Science ®Google Scholar
• Daemen J, Serruys PW. 2007. Drug-eluting stent update 2007: part II: unsettled issues. Circulation. 116(8):961–968.
   PubMed Web of Science ®Google Scholar
• Danckwerts M, Fassihi A. 1991. Implantable controlled release drug delivery systems: a review. Drug Dev Indust Pharm. 17(11):1465–1502.
   Web of Science ®Google Scholar
• Dash AK, Cudworth GC, 2nd. 1998. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods. 40(1):1–12.
   PubMed Web of Science ®Google Scholar
• Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH. 2018. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 132:104–138.
   PubMed Web of Science ®Google Scholar
• de Fátima Pereira A, Mara da Costa V, Cristina Magalhães Santos M, Maciel de A Ribeiro RI, Gabriela Silva A, Carmo Horta Pinto F, Vieira Teixeira Vidigal P, Rodrigues Da Silva G. 2014. Evaluation of the effects of methotrexate released from polymeric implants in solid Ehrlich tumor. Biomed Pharmacother. 68(3):365–368.
   PubMed Web of Science ®Google Scholar
• Dijkman GA, Fernandez del Moral P, Plasman JWMH, Kums JJM, Delaere KPJ, Debruyne FMJ, Hutchinson FJ, Furr BJA. 1990. A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer. J Steroid Biochem Mol Biol. 37(6):933–936.
   PubMed Web of Science ®Google Scholar
• Duvan CI. 2017. Effects of the etonogestrel contraceptive implant (Implanon®) on bone metabolism during lactation: a prospective study. J Fam Plann Reprod Health Care. 43(2):113–117.
   PubMedGoogle Scholar
• Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ, et al. 2015. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 86(5):611–622.
   PubMed Web of Science ®Google Scholar
• Ene CI, Nerva JD, Morton RP, Barkley AS, Barber JK, Ko AL, Silbergeld DL. 2016. Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors. Surg Neurol Int. 7(12):295–S299.
   Google Scholar
• Fakhari A, Subramony J. 2015. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. J Control Release. 220(Pt A):465–475.
   PubMed Web of Science ®Google Scholar
• Fareed A, Stout S, Casarella J, Vayalapalli S, Cox J, Drexler K. 2011. Illicit opioid intoxication: diagnosis and treatment. Subst Abuse. 5:17–25.
   PubMedGoogle Scholar
• Fellner C. 2017. New schizophrenia treatments address unmet clinical needs. P T. 42(2):130–134.
   PubMedGoogle Scholar
• Felt-Baeyens O, Eperon S, Mora P, Limal D, Sagodira S, Breton P, Simonazzi B, Bossy-Nobs L, Guex-Crosier Y, Gurny R, et al. 2006. Biodegradable scleral implants as new triamcinolone acetonide delivery systems. Int J Pharm. 322(1-2):6–12.
   PubMed Web of Science ®Google Scholar
• Finer LB, Zolna MR. 2016. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 374(9):843–852.
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. 2007. Vascular responses to drug eluting stents: importance of delayed healing. ATVB. 27(7):1500–1510.
   Google Scholar
• Folkman J, Long DM, Rosenbaum R. 1966. Silicone rubber: a new diffusion property useful for general anesthesia. Science. 154(3745):148–149.
   PubMed Web of Science ®Google Scholar
• Fonseca AC, Serra AC, Coelho JFJ. 2015. Bioabsorbable polymers in cancer therapy: latest developments. EPMA J. 6:22.
   PubMed Web of Science ®Google Scholar
• Friend DR. 2016. Development of controlled release systems over the past 50 years in the area of contraception. J Control Release. 240:235–241.
   PubMed Web of Science ®Google Scholar
• Ghalanbor Z, Körber M, Bodmeier R. 2012. Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release. Int J Pharm. 438(1-2):302–306.
   PubMed Web of Science ®Google Scholar
• Ghalanbor Z, Körber M, Bodmeier R. 2013. Interdependency of protein-release completeness and polymer degradation in PLGA-based implants. Eur J Pharm Biopharm. 85(3):624–630.
   PubMed Web of Science ®Google Scholar
• Gimeno M, Pinczowski P, Pérez M, Giorello A, Martínez MÁ, Santamaría J, Arruebo M, Luján L. 2015. A controlled antibiotic release system to prevent orthopedic-implant associated infections: an in vitro study. Eur J Pharm Biopharm. 96:264–271.
   PubMed Web of Science ®Google Scholar
• Gordon MS, Vocci FJ, Fitzgerald TT, O'Grady KE, O'Brien CP. 2017. Extended-release naltrexone for pre-release prisoners: a randomized trial of medical mobile treatment. Contemp Clin Trials. 53:130–136.
   PubMed Web of Science ®Google Scholar
• Grossman R, Burger P, Soudry E, Tyler B, Chaichana KL, Weingart J, Olivi A, Gallia GL, Sidransky D, Quiñones-Hinojosa A, et al. 2015. MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel. J Clin Neurosci. 22(12):1938–1942.
   PubMed Web of Science ®Google Scholar
• Grossman SA, Roberts N. 2011. Analgesic applications for a subcutaneous implant that continuously releases hydromorphone. Eur J Pain Suppl. 5(S2):439–442.
   Google Scholar
• Gulati K, Aw MS, Findlay D, Losic D. 2012. Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays. Ther Deliv. 3(7):857–873.
   PubMedGoogle Scholar
• Guo W, Quan P, Fang L, Cun D, Yang M. 2015. Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study. Asian J Pharm Sci. 10(5):405–414.
   Web of Science ®Google Scholar
• Guse C, Koennings S, Kreye F, Siepmann F, Goepferich A, Siepmann J. 2006. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. Int J Pharm. 314(2):137–144.
   PubMed Web of Science ®Google Scholar
• Halpern V, Stalter RM, Owen DH, Dorflinger LJ, Lendvay A, Rademacher KH. 2015. Towards the development of a longer-acting injectable contraceptive: past research and current trends. Contraception. 92(1):3–9.
   PubMed Web of Science ®Google Scholar
• Hamlekhan A, Sinha-Ray S, Takoudis C, Mathew MT, Sukotjo C, Yarin AL, Shokuhfar T. 2015. Fabrication of drug eluting implants: study of drug release mechanism from titanium dioxide nanotubes. J Phys D Appl Phys. 48(27):275401.
   PubMed Web of Science ®Google Scholar
• Hellegaard L, Hansen TB. 2014. Long term follow up in patients with radiologically loose trapeziometacarpal total joint implants. Rheumatology (Sunnyvale). S4(011):2161–1149.
   Google Scholar
• Herrmann S, Winter G, Mohl S, Siepmann F, Siepmann J. 2007. Mechanisms controlling protein release from lipidic implants: effects of PEG addition. J Control Release. 118(2):161–168.
   PubMed Web of Science ®Google Scholar
• Hickey M, d’Arcangues C. 2002. Vaginal bleeding disturbances and implantable contraceptives. Contraception. 65(1):75–84.
   PubMed Web of Science ®Google Scholar
• Hickok N, Shapiro I. 2012. Immobilized antibiotics to prevent orthopaedic implant infections. Adv Drug Deliv Rev. 64(12):1165–1176.
   PubMed Web of Science ®Google Scholar
• Hill A, Geißler S, Weigandt M, Mäder K. 2012. Controlled delivery of nanosuspensions from osmotic pumps: zero order and non-zero order kinetics. J Control Release. 158(3):403–412.
   PubMed Web of Science ®Google Scholar
• Hoffman AS. 2008. The origins and evolution of “controlled” drug delivery systems. J Control Release. 132(3):153–163.
   PubMed Web of Science ®Google Scholar
• Horiuchi S, Winter G. 2015. CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology. Eur J Pharm Biopharm. 92:8–14.
   PubMed Web of Science ®Google Scholar
• Hu M, Shen Y, Zhang L, Qiu L. 2016. Polymersomes via self-assembly of amphiphilic β-cyclodextrin-centered triarm star polymers for enhanced oral bioavailability of water-soluble chemotherapeutics. Biomacromolecules. 17(3):1026–1039.
   PubMed Web of Science ®Google Scholar
• Hulse GK, Tait RJ, Comer SD, Sullivan MA, Jacobs IG, Arnold-Reed D. 2005. Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend. 79(3):351–357.
   PubMed Web of Science ®Google Scholar
• Hwang C-W, Wu D, Edelman ER. 2001. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 104(5):600–605.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Barr WH, Karnes HT. 2007. Characterization of a potential medium for ‘biorelevant’ in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method. J Pharm Biomed Anal. 43(3):845–853.
   PubMed Web of Science ®Google Scholar
• Jain NK, Sahni N, Kumru OS, Joshi SB, Volkin DB, Russell Middaugh C. 2015. Formulation and stabilization of recombinant protein based virus-like particle vaccines. Adv Drug Deliv Rev. 93:42–55.
   PubMed Web of Science ®Google Scholar
• Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 2018. 3D printing in pharmaceutical and medical applications – Recent achievements and challenges. Pharm Res. 35(9):176.
   PubMed Web of Science ®Google Scholar
• Jassim-Jaboori AH, Oyewumi MO. 2015. 3D printing technology in pharmaceutical drug delivery: prospects and challenges. J Biomol Res Ther. 4(4):e141.
   Google Scholar
• Jose PA, Gv PC. 2018. 3D printing of pharmaceuticals – A potential technology in developing personalized medicine. Asian J Pharm Res Dev. 6(3):46–54.
   Google Scholar
• Kang YM, Kim GH, Kim JI, Kim DY, Lee BN, Yoon SM, Kim JH, Kim MS. 2011. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Biomaterials. 32(20):4556–4564.
   PubMed Web of Science ®Google Scholar
• Kasten BB, Arend RC, Katre AA, Kim H, Fan J, Ferrone S, Zinn KR, Buchsbaum DJ. 2017. B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models. Nucl Med Biol. 47:23–30.
   PubMed Web of Science ®Google Scholar
• Kempe S, Mäder K. 2012. In situ forming implants – An attractive formulation principle for parenteral depot formulations. J Control Release. 161(2):668–679.
   PubMed Web of Science ®Google Scholar
• Kempen DHR, Lu L, Classic KL, Hefferan TE, Creemers LB, Maran A, Dhert WJA, Yaszemski MJ. 2008. Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants. J Control Release. 130(1):15–21.
   PubMed Web of Science ®Google Scholar
• Kettenberger U, Latypova A, Terrier A, Pioletti DP. 2015. Time course of bone screw fixation following a local delivery of Zoledronate in a rat femoral model-a micro-finite element analysis. J Mecha Behav Biomed Mater. 45:22–31.
   PubMed Web of Science ®Google Scholar
• Khan T, Mahler H, Kishore R. 2015. Key interactions of surfactants in therapeutic protein formulations: a review. Eur J Pharm Biopharm. 97(Pt A):60–67.
   PubMed Web of Science ®Google Scholar
• Kim PS, Li S, Deer TR, Wallace MS, Staats P. 2018., Intrathecal drug delivery systems. In: Manchikanti L, Kaye AD, Falco FJE, Hirsch JA, editors. Essentials of interventional techniques in managing chronic pain, Switzerland: Springer Nature. p. 671–681.
   Google Scholar
• Kleiner LW, Wright JC, Wang Y. 2014. Evolution of implantable and insertable drug delivery systems. J Control Release. 181:1–10.
   PubMed Web of Science ®Google Scholar
• Kluin OS, van der Mei HC, Busscher HJ, Neut D. 2013. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv. 10(3):341–351.
   PubMed Web of Science ®Google Scholar
• Konkle ATM, Sreter KB, Baker SL, Bielajew C. 2003. Chronic paroxetine infusion influences macronutrient selection in male Sprague–Dawley rats. Pharmacol Biochem Behav. 74(4):883–890.
   PubMed Web of Science ®Google Scholar
• Kost J, Langer R. 2012. Responsive polymeric delivery systems. Adv Drug Deliv Rev. 64:327–341.
   Web of Science ®Google Scholar
• Kozai TDY, Jaquins-Gerstl AS, Vazquez AL, Michael AC, Cui XT. 2015. Brain tissue responses to neural implants impact signal sensitivity and intervention strategies. ACS Chem Neurosci. 6(1):48–67.
   PubMed Web of Science ®Google Scholar
• Krenzlin S, Vincent C, Munzke L, Gnansia D, Siepmann J, Siepmann F. 2012. Predictability of drug release from cochlear implants. J Control Release. 159(1):60–68.
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Siepmann J. 2011. Drug release mechanisms of compressed lipid implants. Int J Pharm. 404(1-2):27–35.
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Willart JF, Descamps M, Siepmann J. 2011. Drug release mechanisms of cast lipid implants. Eur J Pharm Biopharm. 78(3):394–400.
   PubMed Web of Science ®Google Scholar
• Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H. 2010. Retention in naltrexone implant treatment for opioid dependence. Drug Alcohol Depend. 111(1-2):166–169.
   PubMed Web of Science ®Google Scholar
• Kunou N, Ogura Y, Hashizoe M, Honda Y, Hyon S-H, Ikada Y. 1995. Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits. J Control Release. 37(1-2):143–150.
   Web of Science ®Google Scholar
• Lakha F, Henderson C, Glasier A. 2005. The acceptability of self-administration of subcutaneous Depo-Provera. Contraception. 72(1):14–18.
   PubMed Web of Science ®Google Scholar
• Langer R, Peppas NA. 2003. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 49(12):2990–3006.
   Web of Science ®Google Scholar
• Lee SS, Hughes P, Ross AD, Robinson MR. 2010. Biodegradable implants for sustained drug release in the eye. Pharm Res. 27(10):2043–2053.
   PubMed Web of Science ®Google Scholar
• Lesser GJ, Grossman SA, Leong KW, Lo H, Eller S. 1996. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain. 65(2):265–272.
   PubMed Web of Science ®Google Scholar
• Li J, Chu MKL, Gordijo CR, Abbasi AZ, Chen K, Adissu HA, Löhn M, Giacca A, Plettenburg O, Wu XY, et al. 2015. Microfabricated microporous membranes reduce the host immune response and prolong the functional lifetime of a closed-loop insulin delivery implant in a type 1 diabetic rat model. Biomaterials. 47:51–61.
   PubMed Web of Science ®Google Scholar
• Liu L, Gao Q, Lu X, Zhou H. 2016. In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration. Asian J Pharm Sci. 11(6):673–683.
   Web of Science ®Google Scholar
• Liu Q, Zhang H, Zhou G, Xie S, Zou H, Yu Y, Li G, Sun D, Zhang G, Lu Y, et al. 2010. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants. Int J Pharm. 397(1-2):122–129.
   PubMed Web of Science ®Google Scholar
• Lo KW-H, Ulery BD, Ashe KM, Laurencin CT. 2012. Studies of bone morphogenetic protein-based surgical repair. Adv Drug Deliv Rev. 64(12):1277–1291.
   PubMed Web of Science ®Google Scholar
• Lunde B, Littman L, Stimmel S, Rana R, Jacobs A, Horowitz CR. 2017. “Just wear dark underpants mainly”: learning from adolescents' and young adults' experiences with early discontinuation of the contraceptive implant. J Pediatr Adolesc Gynecol. 30(3):395–399.
   PubMed Web of Science ®Google Scholar
• Madhusudanan P, Reade S, Shankarappa S. 2017. Neuroglia as targets for drug delivery systems: a review. Nanomedicine. 13(2):667–679.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3(3):1377–1397.
   PubMed Web of Science ®Google Scholar
• Mangraviti A, Gullotti D, Tyler B, Brem H. 2016. Nanobiotechnology-based delivery strategies: new frontiers in brain tumor targeted therapies. J Control Release. 240:443–453.
   PubMed Web of Science ®Google Scholar
• Mansoor S, Kuppermann B, Kenney M. 2009. Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm Res. 26(4):770–784.
   PubMed Web of Science ®Google Scholar
• Marienfeld C, Iheanacho T, Issa M, Rosenheck RA. 2014. Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study. Addict Behav. 39(2):434–438.
   PubMed Web of Science ®Google Scholar
• McNicholas C, Swor E, Wan L, Peipert JF. 2017. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device – Two years beyond FDA-approved duration. Am J Obstet Gynecol. 216(6):586.e1–586.e6.
   PubMed Web of Science ®Google Scholar
• Meng E, Hoang T. 2012. Micro-and nano-fabricated implantable drug-delivery systems. Ther Deliv. 3(12):1457–1467.
   PubMedGoogle Scholar
• Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, et al. 2006. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology. 190(2):201–211.
   PubMed Web of Science ®Google Scholar
• Mohammad Zaki AJ, Patil SK, Baviskar DT, Jain DK. 2012. Implantable drug delivery system: a review. Int J PharmTech Res. 4(1):280–292.
   Google Scholar
• Mosafer J, Abnous K, Tafaghodi M, Mokhtarzadeh A, Ramezani M. 2017. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Eur J Pharm Biopharm. 113:60–74.
   PubMed Web of Science ®Google Scholar
• Moscicka AE, Czarnecka K, Ciach T. 2007. IntelliDrug implant for medicine delivery in alzheimer’s disease treatment. Macromol Symp. 253(1):134–138.
   Google Scholar
• Nanaki S, Siafaka PI, Zachariadou D, Nerantzaki M, Giliopoulos DJ, Triantafyllidis KS, Kostoglou M, Nikolakaki E, Bikiaris DN. 2017. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy. Eur J Pharm Sci. 99:32–44.
   PubMed Web of Science ®Google Scholar
• Narvekar M, Xue HY, Eoh JY, Wong HL. 2014. Nanocarrier for poorly water-soluble anticancer drugs-barriers of translation and solutions. AAPS PharmSciTech. 15(4):822–833.
   PubMed Web of Science ®Google Scholar
• Navitha A, Jogala S, Krishnamohan C, Aukunuru J. 2014. Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies. J Adv Pharm Technol Res. 5(2):84–89.
   PubMedGoogle Scholar
• Newman M, Benoit D. 2016. Local and targeted drug delivery for bone regeneration. Curr Opin Biotechnol. 40:125–132.
   PubMed Web of Science ®Google Scholar
• Nikam N, Steinberg TB, Steinberg DH. 2014. Advances in stent technologies and their effect on clinical efficacy and safety. Med Devices (Auckland). 7:165–178.
   PubMedGoogle Scholar
• Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. 2017. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 108:39–50.
   PubMed Web of Science ®Google Scholar
• Norouzi M, Nazari B, Miller D. 2016. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 21(11):1835–1849.
   PubMed Web of Science ®Google Scholar
• Ormiston JA, Serruys PWS. 2009. Bioabsorbable coronary stents. Circ Cardiovasc Interv. 2(3):255–260.
   PubMed Web of Science ®Google Scholar
• Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. 2013. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release. 172(1):292–304.
   PubMed Web of Science ®Google Scholar
• Park C-W, Lee H-J, Oh D-W, Kang J-H, Han C-S, Kim D-W. 2018. Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection. DDDT. Volume 12:711–719.
   Web of Science ®Google Scholar
• Park J, Aryal M, Vykhodtseva N, Zhang Y-Z, McDannold N. 2017. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release. 250:77–85.
   PubMed Web of Science ®Google Scholar
• Pilon RN, Narang S, Desai SP. 2016. A report on the consequences of the first implanted device for long-term analgesia in refractory cancer pain. J Clin Anesth. 32:289–293.
   PubMed Web of Science ®Google Scholar
• Pourgholi F, Hajivalili M, Farhad J-N, Kafil HS, Yousefi M. 2016. Nanoparticles: novel vehicles in treatment of Glioblastoma. Biomed Pharmacother. 77:98–107.
   PubMed Web of Science ®Google Scholar
• Rabin C, Liang Y, Ehrlichman RS, Budhian A, Metzger KL, Majewski-Tiedeken C, Winey KI, Siegel SJ. 2008. In vitro and in vivo demonstration of risperidone implants in mice. Schizophr Res. 98(1-3):66–78.
   PubMed Web of Science ®Google Scholar
• Rajagopal K, Wood J, Tran B, Patapoff TW, Nivaggioli T. 2013. Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery. J Pharm Sci. 102(8):2655–2666.
   PubMed Web of Science ®Google Scholar
• Rassner MP, Hebel JM, Altenmüller D-M, Volz S, Herrmann LS, Feuerstein TJ, Freiman TM. 2015. Reduction of epileptiform activity through local valproate-implants in a rat neocortical epilepsy model. Seizure. 30:6–13.
   PubMed Web of Science ®Google Scholar
• Ravivarapu H, Moyer K, Dunn R. 2000. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant. AAPS PharmSciTech. 1(1):1–8.
   Google Scholar
• Ren S, Dai Y, Li C, Qiu Z, Wang X, Tian F, Zhou S, Liu Q, Xing H, Lu Y, et al. 2016. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin. Eur J Pharm Sci. 92:137–145.
   PubMed Web of Science ®Google Scholar
• Restrepo CE, Spinner RJ. 2016. Major nerve injury after contraceptive implant removal: case illustration. J Neurosurg. 124(1):188–189.
   PubMed Web of Science ®Google Scholar
• Richards M, Teal SB, Sheeder J. 2017. Risk of luteal phase pregnancy with any-cycle-day initiation of subdermal contraceptive implants. Contraception. 95(4):364–370.
   PubMed Web of Science ®Google Scholar
• Roke C, Roberts H, Whitehead A. 2016. New Zealand women’s experience during their first year of Jadelle® contraceptive implant. J Prim Health Care. 8(1):13–19.
   PubMed Web of Science ®Google Scholar
• Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ. 2016. Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine. A randomized clinical trial. JAMA. 316(3):282–290.
   PubMed Web of Science ®Google Scholar
• Rothen-Weinhold A, Besseghir K, Vuaridel E, Sublet E, Oudry N, Gurny R. 1999. Stability studies of a somatostatin analogue in biodegradable implants. Int J Pharm. 178(2):213–221.
   PubMed Web of Science ®Google Scholar
• Sanjay ST, Zhou W, Dou M, Tavakoli H, Ma L, Xu F, Li X. 2018. Recent advances of controlled drug delivery using microfluidic platforms. Adv Drug Deliv Rev. 128:3–28.
   PubMed Web of Science ®Google Scholar
• Sedgh G, Ashford LS, Hussain R. 2016. Unmet need for contraception in developing countries: examining women’s reasons for not using a method. New York: Guttmacher Institute.
   Google Scholar
• Seng P, Bayle S, Alliez A, Romain F, Casanova D, Stein A. 2015. The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the South of France. Int J Infect Dis. 35:62–66.
   PubMed Web of Science ®Google Scholar
• Sepahvandi A, Eskandari M, Moztarzadeh F. 2016. Drug delivery systems to the posterior segment of the eye: implants and nanoparticles. BioNanoSci. 6(4):276–283.
   Web of Science ®Google Scholar
• Serruys PW, Kutryk MJB, Ong ATL. 2006. Coronary-artery stents. N Engl J Med. 354(5):483–495.
   PubMed Web of Science ®Google Scholar
• Shemesh S, Kosashvili Y, Groshar D, Bernstine H, Sidon E, Cohen N, Luria T, Velkes S. 2015. The value of 18-FDG PET/CT in the diagnosis and management of implant-related infections of the tibia: a case series. Injury. 46(7):1377–1382.
   PubMed Web of Science ®Google Scholar
• Siegel SJ, Winey KI, Gur RE, Lenox RH, Bilker WB, Ikeda D, Gandhi N, Zhang WX. 2002. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology. 26(6):817–823.
   PubMed Web of Science ®Google Scholar
• Siegel SJ. 2005. Extended release drug delivery strategies in psychiatry: theory to practice. Psychiatry. 2(6):22–31.
   PubMedGoogle Scholar
• Silva-Boghossian CM, Luiz RR, Colombo APV. 2009. Periodontal status, sociodemographic, and behavioral indicators in subjects attending a public dental school in Brazil: analysis of clinical attachment loss. J Periodontol. 80(12):1945–1954.
   PubMed Web of Science ®Google Scholar
• Silva-Boghossian CM, Neves AB, Resende FAR, Colombo APV. 2013. Suppuration-associated bacteria in patients with chronic and aggressive periodontitis. J Periodontol. 84(9):e9–e16.
   PubMed Web of Science ®Google Scholar
• Singh K, Chye GC. 1998. Adverse effects associated with contraceptive implants: incidence, prevention and management. Adv Contracept. 14(1):1–13.
   PubMedGoogle Scholar
• Solanki HK, Thakkar JH, Jani GK. 2010. Recent advances in implantable drug delivery. Int J Pharm Sci Rev Res. 4(3):168–177.
   Google Scholar
• Soo PL, Cho J, Grant J, Ho E, Piquette-Miller M, Allen C. 2008. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. Eur J Pharm Biopharm. 69(1):149–157.
   PubMed Web of Science ®Google Scholar
• Stanback J, Spieler J, Shah I, Finger WR. 2010. Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Contraception. 81(3):181–184.
   PubMed Web of Science ®Google Scholar
• Stanković M, de Waard H, Steendam R, Hiemstra C, Zuidema J, Frijlink HW, Hinrichs WLJ. 2013. Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery. Eur J Pharm Sci. 49(4):578–587.
   PubMed Web of Science ®Google Scholar
• Stanković M, Hiemstra C, de Waard H, Zuidema J, Steendam R, Frijlink HW, Hinrichs WLJ. 2015. Protein release from water-swellable poly(d,l-lactide-PEG)-b-poly(ϵ-caprolactone) implants. Int J Pharm. 480(1-2):73–83.
   PubMed Web of Science ®Google Scholar
• Stotts AL, Dodrill CL, Kosten TR. 2009. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 10(11):1727–1740.
   PubMed Web of Science ®Google Scholar
• Sutherland EG, Otterness C, Janowitz B. 2011. What happens to contraceptive use after injectables are introduced? an analysis of 13 countries. Int Perspect Sex Reprod Health. 37(04):202–208.
   PubMed Web of Science ®Google Scholar
• Talebian S, Foroughi J, Wade SJ, Vine KL, Dolatshahi-Pirouz A, Mehrali M, Conde J, Wallace GG. 2018. Biopolymers for antitumor implantable drug delivery systems: recent advances and future outlook. Adv Mater. 30(31):1706665.
   Web of Science ®Google Scholar
• Tamargo RJ, Rossell LA, Kossoff EH, Tyler BM, Ewend MG, Aryanpur JJ. 2002. The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats. Epilepsy Res. 48(3):145–155.
   PubMed Web of Science ®Google Scholar
• Tan KX, Danquah MK, Sidhu A, Ongkudon CM, Lau SY. 2017. Towards targeted cancer therapy: aptamer or oncolytic virus? Eur J Pharm Sci. 96:8–19.
   PubMed Web of Science ®Google Scholar
• Tang Y, Singh J. 2009. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein. Int J Pharm. 365(1-2):34–43.
   PubMed Web of Science ®Google Scholar
• Thakur R, McMillan H, Jones D. 2014. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release. 176:8–23.
   PubMed Web of Science ®Google Scholar
• Tobias IS, Lee H, Engelmayr GC, Jr, Macaya D, Bettinger CJ, Cima MJ. 2010. Zero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric device. J Control Release. 146(3):356–362.
   PubMed Web of Science ®Google Scholar
• Tomme SRV, Storm G, Hennink WE. 2008. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm. 355(1-2):1–18.
   PubMed Web of Science ®Google Scholar
• Towler HM. 2014. New technologies and drugs in the management of diabetic retinopathy. Pract Diab. 31(7):275–280a.
   Google Scholar
• Trajkovski B, Petersen A, Strube P, Mehta M, Duda GN. 2012. Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone. Adv Drug Deliv Rev. 64(12):1142–1151.
   PubMed Web of Science ®Google Scholar
• Tseng Y, Kau Y, Liu S. 2016. Advanced interstitial chemotherapy for treating malignant glioma. Expert Opin Drug Deliv. 13(11):1533–1544.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, et al. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 11(5):551–555.
   PubMed Web of Science ®Google Scholar
• Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, Eğrilmez S, Ertan G, Özer Ö. 2015. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opin Drug Deliv. 12(11):1791–1807.
   PubMed Web of Science ®Google Scholar
• Vakilinezhad MA, Alipour S, Montaseri H. 2018. Fabrication and in vitro evaluation of magnetic PLGA nanoparticles as a potential methotrexate delivery system for breast cancer. J Drug Deliv Sci Tech. 44:467–474.
   Web of Science ®Google Scholar
• Vakilinezhad MA, Amini A, Akbari Javar H, Baha’addini Beigi Zarandi BF, Montaseri H, Dinarvand R. 2018. Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer’s disease animal model reducing Tau hyperphosphorylation. Daru. 26(2):165–177.
   PubMed Web of Science ®Google Scholar
• van der Steen SC, Raavé R, Langerak S, van Houdt L, van Duijnhoven SM, van Lith SA, Massuger LF, Daamen WF, Leenders WP, van Kuppevelt TH. 2017. Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes. Eur J Pharm Biopharm. 113:229–239.
   PubMed Web of Science ®Google Scholar
• Vemulakonda G, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. 2008. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 126(1):18–22.
   PubMedGoogle Scholar
• Villanueva JR, Bravo-Osuna I, Herrero-Vanrell R, Molina Martínez IT, Guzmán Navarro M. 2016. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration. Eur J Pharm Sci. 92:287–297.
   PubMed Web of Science ®Google Scholar
• Villanueva JR, Villanueva LR, Navarro MG. 2017. Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends. Int J Pharm. 516(1-2):342–351.
   PubMed Web of Science ®Google Scholar
• Wadee A, Pillay V, Choonara YE, Du Toit LC, Penny C, Ndesendo VM, Kumar P, Murphy CS. 2011. Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. Expert Opin Drug Deliv. 8(10):1323–1340.
   PubMed Web of Science ®Google Scholar
• Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, et al. 2012. Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery. J Neurosurg. 117(2):340–347.
   PubMed Web of Science ®Google Scholar
• Wang C, Seo S-J, Kim J-S, Lee S-H, Jeon J-K, Kim J-W, Kim K-H, Kim J-K, Park J. 2018. Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery. J Control Release. 283:105–112.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang A, Joshi M, Christoforidis J. 2013. Drug delivery implants in the treatment of vitreous inflammation. Mediators Inflamm. 2013(780634):1.
   Google Scholar
• Wang Q, Huang J-Y, Li H-Q, Zhao AZ-J, Wang Y, Zhang K-Q, Sun H-T, Lai Y-K. 2016. Recent advances on smart TiO2 nanotube platforms for sustainable drug delivery applications. Int J Nanomed. 12:151–165.
   PubMed Web of Science ®Google Scholar
• Weiser J, Saltzman W. 2014. Controlled release for local delivery of drugs: barriers and models. J Control Release. 190:664–673.
   PubMed Web of Science ®Google Scholar
• White J, Bell J, Saunders JB, Williamson P, Makowska M, Farquharson A, Beebe KL. 2009. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence. Drug Alcohol Depend. 103(1-2):37–43.
   PubMed Web of Science ®Google Scholar
• Wildemann B, Kandziora F, Krummrey G, Palasdies N, Haas NP, Raschke M, Schmidmaier G. 2004. Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle. J Control Release. 95(2):249–256.
   PubMed Web of Science ®Google Scholar
• Wilz A, Pritchard EM, Li T, Lan J-Q, Kaplan DL, Boison D. 2008. Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials. 29(26):3609–3616.
   PubMed Web of Science ®Google Scholar
• Winkelmuller M, Winkelmuller W. 1996. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 85:458–467.
   PubMed Web of Science ®Google Scholar
• Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. 2012. Effectiveness of long-acting reversible contraception. N Engl J Med. 366(21):1998–2007.
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Colson YL, Grinstaff MW. 2012. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 159(1):14–26.
   PubMed Web of Science ®Google Scholar
• Wright JC, Tao Leonard S, Stevenson CL, Beck JC, Chen G, Jao RM, Johnson PA, Leonard J, Skowronski RJ. 2001. An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. J Control Release. 75(1-2):1–10.
   PubMed Web of Science ®Google Scholar
• Xu H-L, Mao K-L, Lu C-T, Fan Z-L, Yang J-J, Xu J, Chen P-P, ZhuGe D-L, Shen B-X, Jin B-H, et al. 2016. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Biomaterials. 107:44–60.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Inami S, Okamatsu K, Ohba T, Ibuki C, Hata N, et al. 2011. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy. Am Heart J. 161(6):1200–1206.
   PubMed Web of Science ®Google Scholar
• Yasin MN, Svirskis D, Seyfoddin A, Rupenthal ID. 2014. Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems. J Control Release. 196:208–221.
   PubMed Web of Science ®Google Scholar
• Ye X, Shokrollahi K, Rozen WM, Conyers R, Wright P, Kenner L, Turner SD, Whitaker IS. 2014. Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence. Mutat Res Rev Mutat Res. 762:123–132.
   PubMed Web of Science ®Google Scholar
• Yi H-G, Choi Y-J, Kang KS, Hong JM, Pati RG, Park MN, Shim IK, Lee CM, Kim SC, Cho D-W. 2016. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release. 238:231–241.
   PubMed Web of Science ®Google Scholar
• Zhang F. 2008. Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion. Biomaterials. 36:4751–4759.
   Web of Science ®Google Scholar
• Zhang J, Feng X, Patil H, Tiwari RV, Repka MA. 2017. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 519(1-2):186–197.
   PubMed Web of Science ®Google Scholar
• Zhou T, Lewis H, Foster RE, Schwendeman SP. 1998. Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy. J Control Release. 55(2-3):281–295.
   PubMed Web of Science ®Google Scholar
• Zou X, Xue Q, Li H, Bünger M, Lind M, Bünger C. 2003. Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices. An experimental study on spinal fusion in pigs. Acta Orthop Scand. 74(5):596–603.
   PubMed Web of Science ®Google Scholar